|
 |
Ad Astra Diagnostics, Inc.
Real-time, patient-side diagnostics that enable fast health decisions for all. That’s better care for patients and streamlined efficiency for providers and payers. Ad Astra Diagnostics is developing the fastest need-to-result complete blood count (CBC) that goes anywhere to increase access – QScout® CBC.
|
|
 |
Bacteromic
Bacteromic develops and delivers the most advanced antimicrobial susceptibility testing system, revolutionizing the treatment of bacterial infections with rapid and comprehensive information. At the same time, Bacteromic actively raises global awareness and commitment to combating antibiotic resistance, with the goal of rapidly resolving bacterial infections for every patient worldwide.
|
|
 |
DxPx Capital
DxPx Capital is an active community of business angels and life-science investors that invests in and supports innovations in diagnostics, digital health, precision medicine, and life science tools. It creates a collaborative network for investors to share insights, build partnerships, and access curated, high-quality deal flow. DxPx Capital provides privileged access to investment opportunities sourced from the DxPx Conference and the DxPx Pitch Business Plan Competition, with startup selection and investment documentation prepared by experienced industry experts.
|
|
 |
Genomtec
Genomtec is a medtech company focused on developing and commercializing innovative molecular diagnostics for clinical use. Its flagship product, Genomtec ID, is a mobile point of care genetic testing platform using patented SNAAT® contactless heating/detection and isothermal nucleic acid amplification (LAMP) to detect pathogens (viruses, bacteria, fungi) and genetic mutations from common sample types. The company primarily serves the clinical diagnostics market in decentralized settings such as primary care clinics, pharmacies, doctors’ offices, and hospital emergency departments.
|
|
 |
Loop Diagnostics
Loop-dx (Loop Diagnostics) is a biotech company developing in vitro diagnostic technology for the early identification of bloodstream infections, including sepsis, by measuring the patient’s immune response. Its main product is SeptiLoop®, a CE marked (IVDR Class C) and UKCA cleared lateral flow IVD that detects bacteremia induced immunosuppression in as little as one hour using LPS stimulated whole blood. It primarily serves hospitals and clinical settings—especially emergency departments and healthcare professionals managing sepsis and bloodstream infections.
|
|
 |
LRE Medical
LRE Medical is an end to end CDMO partner that develops, industrializes, and manufactures complex diagnostic, medical, and life sciences instruments. It supports the full product lifecycle—from product and process development and design transfer through scalable serial production, lifecycle management, and after sales support—helping partners bring high quality devices to market faster and in full regulatory compliance. The company’s core focus is on point of care testing and benchtop molecular diagnostics.
|
|
 |
MiCareo
MiCareo develops automated liquid biopsy and rare cell diagnostics technologies that isolate high purity live rare cells and perform multiplexed fluorescence imaging for quantitative single cell analysis. Its main systems include the MiSelect R II for consistent capture and isolation of circulating tumor cells (CTCs), immune cells, and other rare cells for downstream workflows such as single cell sequencing, and the MiCount system for lower cost rare subpopulation detection with AI driven automation.
|
|
 |
Mimark Diagnostics
MiMark develops protein based diagnostics that use a simple, minimally invasive gynecological fluid sample to diagnose gynecological diseases efficiently and accurately. The company has standardized gynecological fluid sample handling and built the GyLDa platform, translating mass spectrometry protein biomarker discoveries into proprietary key reagents and validated immunoassays. MiMark’s solutions are designed for implementation in clinical laboratories and aim to make women’s health diagnostics simpler, safer, and more cost effective.
|
|
 |
Sapphiros
Sapphiros is a consumer diagnostics company founded to close gaps in health testing by making fast, reliable healthcare testing accessible directly in people’s hands, beyond labs and clinics. It develops innovative diagnostic technologies and brings them from scientific discovery through large scale manufacturing to support everyday health management. Sapphiros works with partners across global health and government—including organizations like the Gates Foundation and the NIH—to expand equitable access to testing in multiple markets.
|
|
 |
We Venture Capital
We Venture Capital is the corporate venture arm of Werfen, a worldwide leader in Specialized Diagnostics. It invests globally in early stage diagnostics start ups close to market entry and early scale ups, and also backs digital solutions and life science tools disrupting the diagnostics arena. Beyond capital, it partners actively with portfolio companies, leveraging Werfen’s strategic insight, global reach, diagnostics know how, and network.
|
|
 |
Wellumio
Wellumio is transforming stroke care by improving access to MRI technology for faster, front line diagnosis. Its main product, axana®, is a portable, faster, energy efficient MRI system based on Pulsed Gradient Free Mapping that delivers proven MRI tissue contrast and is designed to accelerate clinical workflows. Wellumio focuses on acute stroke detection and diagnostics, leveraging MRI’s soft tissue contrast advantages for ischemic stroke and reliability for hemorrhagic stroke.
|